ACADIA PHARMACEUTICALS, INC.
Not Available The goal of this SBIR is to develop ultralightweight, stable, large aperture optics that are suitable for submillimeter, infrared, visible, and LIDAR instruments. Phase I will demonstrat ...SBIR Phase I 2000 Department of Health and Human Services
DESCRIPTION (provided by applicant): Neuropathic pain is a serious neurological disorder affecting approximately 1.8 million people in the United States. It is refractory to standard analgesic therap ...SBIR Phase I 2011 Department of Health and Human Services